Cowen Sees a Buying Opportunity for Stereotaxis (STXS) Investors After NDR, Reiterates Outperform Rating
Tweet Send to a Friend
Cowen analyst Joshua Jennings reiterated an Outperform rating and $9.50 price target on Stereotaxis (NYSE: STXS) noting the company is ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
